SEC Comment Letter 0000000000-24-002075 to Invivyd, Inc. (IVVD) (CIK 0001832038) (IVVD)
Invivyd, Inc. (IVVD) (CIK 0001832038)
Date: Feb. 23, 2024 · CIK: 0001832038 · Accession: 0000000000-24-002075
AI Filing Summary & Sentiment
File numbers found in text: 333-276986
Letter
United States securities and exchange commission logo February 23, 2024 David Hering Chief Executive Officer Invivyd, Inc. 1601 Trapelo Road, Suite 178 Waltham, MA 02451 Re:Invivyd, Inc. Registration Statement on Form S-3 Filed February 9, 2024 File No. 333-276986 Dear David Hering: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen Nicolai
Show Raw Text
United States securities and exchange commission logo
February 23, 2024
David Hering
Chief Executive Officer
Invivyd, Inc.
1601 Trapelo Road, Suite 178
Waltham, MA 02451
Re:Invivyd, Inc.
Registration Statement on Form S-3
Filed February 9, 2024
File No. 333-276986
Dear David Hering:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephen Nicolai